{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:09:19Z","timestamp":1778818159251,"version":"3.51.4"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T00:00:00Z","timestamp":1540166400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["C4107"],"award-info":[{"award-number":["C4107"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02408","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T04:51:27Z","timestamp":1540183887000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia"],"prefix":"10.3389","volume":"9","author":[{"given":"Nadja","family":"Hilger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilly","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Zoennchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Dluczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Halbich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Wickenhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Gerloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander A.","family":"Wurm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Behre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kretschmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Fricke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1182\/blood-2002-09-2866","article-title":"Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors","volume":"102","author":"Ottinger","year":"2003","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3389\/fimmu.2017.00496","article-title":"Graft-versus-Leukemia effect following hematopoietic stem cell transplantation for leukemia","volume":"8","author":"Dickinson","year":"2017","journal-title":"Front Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/bmt.2013.59","article-title":"Prognosis of grade 3-4 acute GVHD continues to be dismal","volume":"48","author":"Jamani","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"B4","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.bbmt.2012.04.006","article-title":"Secondary treatment of acute graft-versus-host disease: a critical review","volume":"18","author":"Martin","year":"2012","journal-title":"Biol.Blood Marrow Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/bjh.13959","article-title":"Advances in understanding the pathogenesis of graft-versus-host disease","volume":"173","author":"Magenau","year":"2016","journal-title":"Br J Haematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3324\/haematol.2008.003103","article-title":"Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab","volume":"94","author":"Matthews","year":"2009","journal-title":"Haematologica"},{"key":"B7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3389\/fimmu.2017.00465","article-title":"Natural killer cells in graft-versus-host-disease after allogeneic hematopoietic cell transplantation","volume":"8","author":"Simonetta","year":"2017","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1084\/jem.20020090","article-title":"CD4+ CD25+ immunoregulatory T cells","volume":"196","author":"Cohen","year":"2002","journal-title":"J Exp Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.blre.2016.03.001","article-title":"Specific removal of alloreactive T-cells to prevent GvHD in hemopoietic stem cell transplantation: rationale, strategies and perspectives","volume":"30","author":"Li","year":"2016","journal-title":"Blood Rev."},{"key":"B10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0952-7915(96)80085-9","article-title":"Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL","volume":"8","author":"Nash","year":"1996","journal-title":"Curr Opin Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.imlet.2015.05.018","article-title":"Challenges and future perspectives of T cell immunotherapy in cancer","volume":"166","author":"de","year":"2015","journal-title":"Immunol Lett."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2014.998538","article-title":"Consensus nomenclature for CD8+ T cell phenotypes in cancer","author":"Apetoh","year":"2015","journal-title":"Oncoimmunology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1146\/annurev.iy.10.040192.000305","article-title":"Sequences and factors: a guide to MHC class-II transcription","volume":"10","author":"Glimcher","year":"1992","journal-title":"Annu Rev Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.yexcr.2017.11.029","article-title":"CD4+ T cell-mediated cytotoxicity is associated with MHC class II expression on malignant CD19+ B cells in diffuse large B cell lymphoma","volume":"362","author":"Zhou","year":"2018","journal-title":"Exp Cell Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.4161\/onci.21205","article-title":"Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy","volume":"1","author":"Thibodeau","year":"2012","journal-title":"Oncoimmunology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: Mechanistic basis and therapeutic strategies","author":"Vinay","year":"2015","journal-title":"Semin Cancer Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12307-012-0127-6","article-title":"Effector CD4 and CD8 T cells and their role in the tumor microenvironment","volume":"6","author":"Hadrup","year":"2013","journal-title":"Cancer Microenviron."},{"key":"B20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/31002","article-title":"T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1158\/0008-5472.CAN-11-3775","article-title":"NFAT1 supports tumor-induced anergy of CD4+ T cells","volume":"72","author":"Abe","year":"2012","journal-title":"Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1073\/pnas.95.3.1178","article-title":"Induction of antigen-specific T cell anergy: an early event in the course of tumor progression","volume":"95","author":"Staveley-O'Carroll","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B23","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.4049\/jimmunol.136.11.4303","article-title":"Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL","volume":"136","author":"Kern","year":"1986","journal-title":"J Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1182\/blood-2012-10-385591","article-title":"The role of B7 family molecules in hematologic malignancy","volume":"121","author":"Greaves","year":"2013","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/cyto.a.22619","article-title":"Flow cytometric analysis of the graft-versus-Leukemia-Effect after hematopoietic stem cell transplantation in mice","volume":"87","author":"Schmidt","year":"2015","journal-title":"Cytometry A"},{"key":"B27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/cyto.a.22930","article-title":"Attenuation of graft-versus-host-disease in NOD scid IL-2Rgamma(-\/-) (NSG) mice by ex vivo modulation of human CD4+ T cells","volume":"89","author":"Hilger","year":"2016","journal-title":"Cytometry A"},{"key":"B28","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.4049\/jimmunol.149.5.1809","article-title":"Effects of CD4 synthetic peptides on HIV type I envelope glycoprotein function","volume":"149","author":"Repke","year":"1992","journal-title":"J Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00018-013-1476-0","article-title":"Prevention of graft-versus-host-disease with preserved graft-versus-leukemia-effect by ex vivo and in vivo modulation of CD4+ T-cells","volume":"71","author":"Fricke","year":"2014","journal-title":"Cell Mol Life Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/ejh.12575","article-title":"Mild chronic graft-versus-host disease may alleviate poor prognosis associated with FLT3 internal tandem duplication for adult acute myeloid leukemia following allogeneic stem cell transplantation with myeloablative conditioning in first complete remission: a retrospective study","volume":"96","author":"Nasilowska-Adamska","year":"2016","journal-title":"Eur J Haematol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s00277-015-2461-5","article-title":"Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation","volume":"94","author":"Tschan-Plessl","year":"2015","journal-title":"Ann Hematol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.4081\/oncol.2012.e8","article-title":"An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment","volume":"6","author":"Grafone","year":"2012","journal-title":"Oncol Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","author":"Stirewalt","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N Engl J Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1182\/blood-2011-02-334748","article-title":"Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers","volume":"118","author":"Rockova","year":"2011","journal-title":"Blood"},{"key":"B36","first-page":"7233","article-title":"Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study","volume":"61","author":"Whitman","year":"2001","journal-title":"Cancer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1182\/blood-2016-09-693648","article-title":"How I treat FLT3-mutated AML","volume":"129","author":"Pratz","year":"2017","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"47018","DOI":"10.18632\/oncotarget.10147","article-title":"Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget."},{"key":"B39","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/annonc\/mdw015","article-title":"New drugs in acute myeloid leukemia","volume":"27","author":"Kadia","year":"2016","journal-title":"Ann Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/JBM.S100283","article-title":"Midostaurin: an emerging treatment for acute myeloid leukemia patients","volume":"7","author":"Gallogly","year":"2016","journal-title":"J Blood Med."},{"key":"B41","unstructured":"EuropeanMedicines Agency Rydapt: Midostaurin2017"},{"key":"B42","unstructured":"2017"},{"key":"B43","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cyto.a.22061","article-title":"Allogeneic bone marrow grafts with high levels of CD4+ CD25+ FoxP3+ T cells can lead to engraftment failure","volume":"81","author":"Fricke","year":"2012","journal-title":"Cytometry A"},{"key":"B44","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","article-title":"An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood.V96.12.3907","article-title":"Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways","volume":"96","author":"Mizuki","year":"2000","journal-title":"Blood."},{"key":"B46","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/leu.2014.231","article-title":"NF-\u03baB\/STAT5\/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia","volume":"29","author":"Gerloff","year":"2015","journal-title":"Leukemia"},{"key":"B47","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3109\/09553002.2014.899443","article-title":"Modelling hematological parameters after total body irradiation","volume":"90","author":"Oelkrug","year":"2014","journal-title":"Int J Radiat Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-60327-409-8_1","article-title":"In situ detection of apoptosis by the TUNEL assay: an overview of techniques","volume":"682","author":"Loo","year":"2011","journal-title":"Methods Mol Biol."},{"key":"B49","volume-title":"An R Companion to Applied Regression","author":"Fox","year":"2011"},{"key":"B50","unstructured":"2017"},{"key":"B51","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/bimj.200810425","article-title":"Simultaneous inference in general parametric models","volume":"50","author":"Hothorn","year":"2008","journal-title":"Biomet J."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.31234\/osf.io\/fzh6c","article-title":"Diamond plots: a tutorial to introduce a visualisation tool that facilitates interpretation and comparison of multiple sample estimates while respecting their inaccuracy","author":"Peters","year":"2017","journal-title":"PsyArXiv"},{"key":"B53","unstructured":"DescTools: Tools for Descriptive Statistics2017"},{"key":"B54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1198\/000313006X118430","article-title":"A lego system for conditional inference","volume":"60","author":"Hothorn","year":"2006","journal-title":"Am Stat."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i08","article-title":"Implementing a class of permutation tests: the coin package","volume":"28","author":"Hothorn","year":"2008","journal-title":"J Stat Softw."},{"key":"B56","author":"Ogle","year":"2018","journal-title":"FSA: Fisheries Stock Analysis"},{"key":"B57","volume-title":"Entwicklung pr\u00e4klinischer Transplantationsmodelle und Innovativer Immunologischer Therapien zur Pr\u00e4vention der Transplantat-Gegen-Wirt-Erkrankung (GvHD) mit Erhaltenem Anti-Tumor-Effekt Nach H\u00e4matopoetischen Stammzelltransplantationen","author":"Fricke","year":"2015"},{"key":"B58","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1148\/rg.342135046","article-title":"Abdominal complications following hematopoietic stem cell transplantation","volume":"34","author":"del","year":"2014","journal-title":"Radiographics"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"B60","unstructured":"Akute Myeloische Leuk\u00e4mie (AML): Leitlinie ICD-10 C92.-, ICD-10 C93.-Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie h\u00e4matologischer und onkologischer Erkrankungen R\u00f6lligC BeelenDW BraessJ GreilR NiederwieserD PasswegJ 2018"},{"key":"B61","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/35077251","article-title":"Haematopoietic cell transplantation as immunotherapy","volume":"411","author":"Appelbaum","year":"2001","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.bbmt.2010.05.019","article-title":"Graft-versus-host disease treatment: predictors of survival","volume":"16","author":"Levine","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e1146842","DOI":"10.1080\/2162402X.2016.1146842","article-title":"CD8+ Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4+ Tregs in mice","volume":"5","author":"Heinrichs","year":"2016","journal-title":"Oncoimmunology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/stem.1867","article-title":"Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation","volume":"33","author":"Auletta","year":"2015","journal-title":"Stem cells"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1055\/s-2002-34942","article-title":"Mutationen des Wachstumsfaktor-Rezeptors Flt3 bei Akuter Myeloischer Leukamie - Transformation myeloischer Zellen durch Ras-abhangige und Ras-unabhangige Mechanismen","volume":"127","author":"M\u00fcller-Tidow","year":"2002","journal-title":"Dtsch Med Wochenschr."},{"key":"B66","doi-asserted-by":"publisher","first-page":"48","DOI":"10.21037\/sci.2017.05.04","article-title":"Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia","volume":"4","author":"Chen","year":"2017","journal-title":"Stem Cell Investig."},{"key":"B67","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1242\/dmm.006668","article-title":"Mouse models of graft-versus-host disease: advances and limitations","volume":"4","author":"Schroeder","year":"2011","journal-title":"Dis Model Mech."},{"key":"B68","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3389\/fimmu.2016.00523","article-title":"Graft immune cell composition associates with clinical outcome of allogeneic hematopoietic stem cell transplantation in patients with AML","volume":"7","author":"Impola","year":"2016","journal-title":"Front Immunol."},{"key":"B69","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","article-title":"T-cell depletion of HLA-identical transplants in leukemia","volume":"78","author":"Marmont","year":"1991","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/icb.2014.102","article-title":"A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway","volume":"93","author":"Helling","year":"2015","journal-title":"Immunol Cell Biol."},{"key":"B71","unstructured":"Next generation sequencing and functional analysis of Mirna expression in acute myeloid leukemia patients with different FLT3 mutations: block of MiR-155 in FLT3-ITD driven AML leads to downregulation of myeloid blasts in vivo2438 GerloffD WurmAA HartmannJU HilgerN M\u00fcllerA-M KatzerkeC Blood1262015"},{"key":"B72","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/bjc.2017.220","article-title":"HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer","volume":"117","author":"Barnes","year":"2017","journal-title":"Br J Cancer"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1182\/blood-2015-06-651562","article-title":"Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation","volume":"126","author":"Schmid","year":"2015","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/bmt.2012.88","article-title":"Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3\/ITD outweighs the conventional markers","volume":"47","author":"Sengsayadeth","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"B75","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/bmt.2015.170","article-title":"FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML","volume":"51","author":"Song","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1158\/1078-0432.CCR-04-1552","article-title":"Risk assessment in patients with acute myeloid leukemia and a normal karyotype","volume":"11","author":"Bienz","year":"2005","journal-title":"Clin Cancer Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.leukres.2010.01.001","article-title":"Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review","volume":"34","author":"Beitinjaneh","year":"2010","journal-title":"Leuk Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"de","year":"2016","journal-title":"Blood Cancer J."},{"key":"B79","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4252\/wjsc.v6.i2.69","article-title":"Allogeneic hematopoietic cell transplant for acute myeloid leukemia: current state in 2013 and future directions","volume":"6","author":"Kanate","year":"2014","journal-title":"World J Stem Cells"},{"key":"B80","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report","volume":"21","author":"Shulman","year":"2015","journal-title":"Biol Blood Marrow Transplant."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02408\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T06:44:34Z","timestamp":1693982674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02408\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,22]]},"references-count":80,"alternative-id":["10.3389\/fimmu.2018.02408"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02408","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,22]]},"article-number":"2408"}}